Risk of active tuberculosis among people with diabetes mellitus: systematic review and meta-analysis

被引:50
作者
Hayashi, Shintaro [1 ]
Chandramohan, Daniel [2 ]
机构
[1] Ichinomiya Nishi Hosp, Kaimei Hira 1, Ichinomiya, Aichi 4940001, Japan
[2] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England
关键词
tuberculosis; diabetes mellitus; risk; systematic review; meta-analysis; PULMONARY TUBERCULOSIS; SOCIOECONOMIC-STATUS; DISEASE; EPIDEMIOLOGY; ASSOCIATION; MORTALITY; COHORT;
D O I
10.1111/tmi.13133
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
ObjectiveTo assess the risk of active TB in people with DM and the factors associated with this risk. MethodsSystematic review and meta-analysis. We searched the literature for studies that reported the effect of DM on TB controlled for the effect of age. Studies that had not established the diagnosis of DM prior to detecting active TB were excluded. Study quality was assessed by Newcastle-Ottawa scale and we conducted a meta-analysis using random-effects models. ResultsOf 14 studies (eight cohort and six case-control studies) that involved 22616623 participants met the selection criteria and were included in the analysis. There was substantial variation between studies in the estimates of the effect of DM on TB. However, the pooled estimates from seven high-quality studies showed that diabetic people have a 1.5-fold increased risk of developing active TB vs. those without DM (95%CI 1.28-1.76), with relatively small heterogeneity (I-2=44%). The increased risk of TB was observed predominantly among DM populations with poor glycaemic control. ConclusionThere is evidence suggesting an increased risk of developing TB among people with DM, and that improving glycaemic control in DM patients would reduce the risk of developing TB. An integrated approach is needed to control the dual burden of DM and TB.
引用
收藏
页码:1058 / 1070
页数:13
相关论文
共 46 条
  • [31] Guidance for Developers of Health Research Reporting Guidelines
    Moher, David
    Schulz, Kenneth F.
    Simera, Iveta
    Altman, Douglas G.
    [J]. PLOS MEDICINE, 2010, 7 (02)
  • [32] THE BENEFITS OF ISONIAZID CHEMOPROPHYLAXIS AND RISK-FACTORS FOR TUBERCULOSIS AMONG OGLALA SIOUX INDIANS
    MORI, MA
    LEONARDSON, G
    WELTY, TK
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1992, 152 (03) : 547 - 550
  • [33] Increased risk of common infections in patients with type 1 and type 2 diabetes Mellitus
    Muller, LMAJ
    Gorter, KJ
    Hak, E
    Goudzwaard, WL
    Schellevis, FG
    Hoepelman, AIM
    Rutten, GEHM
    [J]. CLINICAL INFECTIOUS DISEASES, 2005, 41 (03) : 281 - 288
  • [34] Ndishimye Pacifique, 2017, Clujul Med, V90, P54, DOI 10.15386/cjmed-652
  • [35] NICHOLS GP, 1957, AM REV TUBERC PULM, V76, P1016
  • [36] Risk of tuberculosis in patients with diabetes: population based cohort study using the UK Clinical Practice Research Datalink
    Pealing, Louise
    Wing, Kevin
    Mathur, Rohini
    Prieto-Merino, David
    Smeeth, Liam
    Moore, David A. J.
    [J]. BMC MEDICINE, 2015, 13
  • [37] Peterson J., 2011, The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses, P1
  • [38] PFAFFENBERG R, 1958, Z Tuberk, V111, P167
  • [39] Socio-Demographic and Clinical Differences in Subjects with Tuberculosis with and without Diabetes Mellitus in Brazil - A Multivariate Analysis
    Reis-Santos, Barbara
    Locatelli, Rodrigo
    Horta, Bernardo L.
    Faerstein, Eduardo
    Sanchez, Mauro N.
    Riley, Lee W.
    Maciel, Ethel Leonor
    [J]. PLOS ONE, 2013, 8 (04):
  • [40] Socioeconomic status and diagnosed diabetes incidence
    Robbins, JM
    Vaccarino, V
    Zhang, HP
    Kasl, SV
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2005, 68 (03) : 230 - 236